FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366165096> ?p ?o ?g. }

• W4366165096 endingPage "106774" @default.
• W4366165096 startingPage "106774" @default.
• W4366165096 abstract "Because genetic alterations including mutations, overexpression, translocations, and dysregulation of protein kinases are involved in the pathogenesis of many illnesses, this enzyme family is the target of many drug discovery programs in the pharmaceutical industry. Overall, the US FDA has approved 74 small molecule protein kinase inhibitors, nearly all of which are orally effective. Of the 74 approved drugs, thirty-nine block receptor protein-tyrosine kinases, nineteen target nonreceptor protein-tyrosine kinases, twelve are directed against protein-serine/threonine protein kinases, and four target dual specificity protein kinases. The data indicate that 65 of these medicinals are approved for the management of neoplasms (51 against solid tumors such as breast, colon, and lung cancers, eight against nonsolid tumors such as leukemia, and six against both types of tumors). Nine of the FDA-approved kinase inhibitors form covalent bonds with their target enzymes and they are accordingly classified as TCIs (targeted covalent inhibitors). Medicinal chemists have examined the physicochemical properties of drugs that are orally effective. Lipinski's rule of five (Ro5) is a computational procedure that is used to estimate solubility, membrane permeability, and pharmacological effectiveness in the drug-discovery setting. It relies on four parameters including molecular weight, number of hydrogen bond donors and acceptors, and the Log of the partition coefficient. Other important descriptors include the lipophilic efficiency, the polar surface area, and the number of rotatable bonds and aromatic rings. We tabulated these and other properties of the FDA-approved kinase inhibitors. Of the 74 approved drugs, 30 fail to comply with the rule of five." @default.
• W4366165096 created "2023-04-19" @default.
• W4366165096 creator A5050801402 @default.
• W4366165096 date "2023-05-01" @default.
• W4366165096 modified "2023-09-26" @default.
• W4366165096 title "Rule of five violations among the FDA-approved small molecule protein kinase inhibitors" @default.
• W4366165096 cites W1574994167 @default.
• W4366165096 cites W1718256562 @default.
• W4366165096 cites W1881469793 @default.
• W4366165096 cites W2008525757 @default.
• W4366165096 cites W2030205108 @default.
• W4366165096 cites W2031441006 @default.
• W4366165096 cites W2052016211 @default.
• W4366165096 cites W2062458432 @default.
• W4366165096 cites W2074274985 @default.
• W4366165096 cites W2094234842 @default.
• W4366165096 cites W2105649494 @default.
• W4366165096 cites W2106605095 @default.
• W4366165096 cites W2122995608 @default.
• W4366165096 cites W2135732933 @default.
• W4366165096 cites W2136133297 @default.
• W4366165096 cites W2138778824 @default.
• W4366165096 cites W2141528038 @default.
• W4366165096 cites W2234248612 @default.
• W4366165096 cites W2265028324 @default.
• W4366165096 cites W2286158735 @default.
• W4366165096 cites W2398437686 @default.
• W4366165096 cites W2399539756 @default.
• W4366165096 cites W2461433458 @default.
• W4366165096 cites W2570230847 @default.
• W4366165096 cites W2586891229 @default.
• W4366165096 cites W2778033843 @default.
• W4366165096 cites W2788451340 @default.
• W4366165096 cites W2794867021 @default.
• W4366165096 cites W2799561638 @default.
• W4366165096 cites W2885651891 @default.
• W4366165096 cites W2922159934 @default.
• W4366165096 cites W2947157150 @default.
• W4366165096 cites W2967609070 @default.
• W4366165096 cites W2982688814 @default.
• W4366165096 cites W2995463243 @default.
• W4366165096 cites W2998628971 @default.
• W4366165096 cites W3096583666 @default.
• W4366165096 cites W3119588688 @default.
• W4366165096 cites W3120861427 @default.
• W4366165096 cites W3123446037 @default.
• W4366165096 cites W3123671769 @default.
• W4366165096 cites W3145046568 @default.
• W4366165096 cites W3161074857 @default.
• W4366165096 cites W3163511095 @default.
• W4366165096 cites W3164680581 @default.
• W4366165096 cites W3193746989 @default.
• W4366165096 cites W3203420675 @default.
• W4366165096 cites W4200451060 @default.
• W4366165096 cites W4240976793 @default.
• W4366165096 cites W4255148681 @default.
• W4366165096 cites W4309184823 @default.
• W4366165096 cites W4313441943 @default.
• W4366165096 cites W4317808907 @default.
• W4366165096 cites W4317903197 @default.
• W4366165096 cites W4319304604 @default.
• W4366165096 cites W3119977888 @default.
• W4366165096 doi "https://doi.org/10.1016/j.phrs.2023.106774" @default.
• W4366165096 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37075870" @default.
• W4366165096 hasPublicationYear "2023" @default.
• W4366165096 type Work @default.
• W4366165096 citedByCount "3" @default.
• W4366165096 countsByYear W43661650962023 @default.
• W4366165096 crossrefType "journal-article" @default.
• W4366165096 hasAuthorship W4366165096A5050801402 @default.
• W4366165096 hasBestOaLocation W43661650961 @default.
• W4366165096 hasConcept C104317684 @default.
• W4366165096 hasConcept C161624437 @default.
• W4366165096 hasConcept C184235292 @default.
• W4366165096 hasConcept C185592680 @default.
• W4366165096 hasConcept C2775905019 @default.
• W4366165096 hasConcept C41847442 @default.
• W4366165096 hasConcept C42362537 @default.
• W4366165096 hasConcept C502942594 @default.
• W4366165096 hasConcept C55493867 @default.
• W4366165096 hasConcept C62478195 @default.
• W4366165096 hasConcept C71924100 @default.
• W4366165096 hasConcept C74187038 @default.
• W4366165096 hasConcept C97029542 @default.
• W4366165096 hasConcept C98274493 @default.
• W4366165096 hasConceptScore W4366165096C104317684 @default.
• W4366165096 hasConceptScore W4366165096C161624437 @default.
• W4366165096 hasConceptScore W4366165096C184235292 @default.
• W4366165096 hasConceptScore W4366165096C185592680 @default.
• W4366165096 hasConceptScore W4366165096C2775905019 @default.
• W4366165096 hasConceptScore W4366165096C41847442 @default.
• W4366165096 hasConceptScore W4366165096C42362537 @default.
• W4366165096 hasConceptScore W4366165096C502942594 @default.
• W4366165096 hasConceptScore W4366165096C55493867 @default.
• W4366165096 hasConceptScore W4366165096C62478195 @default.
• W4366165096 hasConceptScore W4366165096C71924100 @default.
• W4366165096 hasConceptScore W4366165096C74187038 @default.
• W4366165096 hasConceptScore W4366165096C97029542 @default.

• next